Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
JAMA Network Open
|
February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial
Matthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.
Infectious Diseases and Therapy
|
June 28, 2024
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
Colleen S Kraft, Matthew Sims, Michael Silverman, et al.
The New England Journal of Medicine
|
January 19, 2022
SER-109, an Oral Microbiome Therapy for Recurrent <i>Clostridioides difficile</i> Infection
Paul Feuerstadt, Thomas J Louie, Bret Lashner, et al.
Open Forum Infectious Diseases
|
May 19, 2023
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections
Daniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, et al.
The New England Journal of Medicine
|
June 13, 2019
Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis
Michael R Wilson, Hannah A Sample, Kelsey C Zorn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2025
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine
Youyi Fong, Yunda Huang, Ying Huang, et al.
Open Forum Infectious Diseases
|
June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case
Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 11, 2025
NCCN Guidelines® Insights: Survivorship, Version 2.2025
Tara Sanft, Andrew T Day, Shannon M Ansbaugh, et al.
The New England Journal of Medicine
|
April 11, 2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Jonathan Grein, Norio Ohmagari, Daniel Shin, et al.
Annals of Internal Medicine
|
November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial
Gail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
JAMA Network Open
|
February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial
Matthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.
Infectious Diseases and Therapy
|
June 28, 2024
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
Colleen S Kraft, Matthew Sims, Michael Silverman, et al.
The New England Journal of Medicine
|
January 19, 2022
SER-109, an Oral Microbiome Therapy for Recurrent <i>Clostridioides difficile</i> Infection
Paul Feuerstadt, Thomas J Louie, Bret Lashner, et al.
Open Forum Infectious Diseases
|
May 19, 2023
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections
Daniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, et al.
The New England Journal of Medicine
|
June 13, 2019
Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis
Michael R Wilson, Hannah A Sample, Kelsey C Zorn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2025
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine
Youyi Fong, Yunda Huang, Ying Huang, et al.
Open Forum Infectious Diseases
|
June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case
Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 11, 2025
NCCN Guidelines® Insights: Survivorship, Version 2.2025
Tara Sanft, Andrew T Day, Shannon M Ansbaugh, et al.
The New England Journal of Medicine
|
April 11, 2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Jonathan Grein, Norio Ohmagari, Daniel Shin, et al.
Annals of Internal Medicine
|
November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial
Gail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
Page
of 8